Latest filing published 14 Sept 2026 for Shanghai Henlius Biotech, Inc. - H Shares, €3,852.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Song Ruilin: trading record in brief
Song Ruilin discloses dealings in Shanghai Henlius Biotech, Inc. - H Shares to HKEX. Over a trading history stretching from 29 August 2026 to 8 September 2026, the count stands at 2 filings.
Sales make up the whole of the open-market record (1 sale, €3,852).
The latest filing, published on 14 September 2026, reports an open-market sale of €3,852 in Shanghai Henlius Biotech, Inc. - H Shares. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by HKEX and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Song Ruilin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 510 shares@ HK$68.8982ShareXHKGHKEX:DA20260911E00478
- 1,650 sharesShareXHKGHKEX:DA20260902E00396
2 of 2 declarations